Recent advances in oral delivery of macromolecular drugs and benefits of polymer conjugation

2017 ◽  
Vol 31 ◽  
pp. 67-74 ◽  
Author(s):  
Kathrin Fuhrmann ◽  
Gregor Fuhrmann
2014 ◽  
Vol 8 (2) ◽  
pp. 155-159 ◽  
Author(s):  
Rekha Ramesan ◽  
Chandra Sharma

2013 ◽  
Vol 65 (6) ◽  
pp. 865-879 ◽  
Author(s):  
Mei-Chin Chen ◽  
Fwu-Long Mi ◽  
Zi-Xian Liao ◽  
Chun-Wen Hsiao ◽  
Kiran Sonaje ◽  
...  

2004 ◽  
Vol 1 (1) ◽  
pp. 87-98 ◽  
Author(s):  
Andreas Bernkop-Schnürch ◽  
Martin H Hoffer ◽  
Krum Kafedjiiski

Nanomedicine ◽  
2021 ◽  
Author(s):  
Eric Mühlberg ◽  
Mira Burtscher ◽  
Florian Umstätter ◽  
Gert Fricker ◽  
Walter Mier ◽  
...  

The number of approved macromolecular drugs such as peptides, proteins and antibodies steadily increases. Since drugs with high molecular weight are commonly not suitable for oral delivery, research on carrier strategies enabling oral administration is of vital interest. In past decades, nanocarriers, in particular liposomes, have been exhaustively investigated as oral drug-delivery platform. Despite their successful application as parenteral delivery vehicles, liposomes have up to date not succeeded for oral administration. However, a plenitude of approaches aiming to increase the oral bioavailability of macromolecular drugs administered by liposomal formulations has been published. Here, we summarize the strategies published in the last 10 years (vaccine strategies excluded) with a main focus on strategies proven efficient in animal models.


2021 ◽  
Vol 602 ◽  
pp. 120598
Author(s):  
Ruxuan Wang ◽  
Qiong Bian ◽  
Yihua Xu ◽  
Donghang Xu ◽  
Jianqing Gao

2015 ◽  
Vol 97 ◽  
pp. 206-217 ◽  
Author(s):  
P. Ojer ◽  
T. Iglesias ◽  
A. Azqueta ◽  
J.M. Irache ◽  
A. López de Cerain

Sign in / Sign up

Export Citation Format

Share Document